Overview

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Non-Fasting Conditions

Status:
Completed

Trial end date:
2001-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate the relative bioavailability of Ribavirin 200 capsules and Rebetol 200 mg capsules in females under non-fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Sandoz

Treatments:

Ribavirin